| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |